AWM Investment Company Inc. Buys 1,240,535 Shares of Aspen Aerogels, Inc. $ASPN

Key Points

• AWM Investment Company Inc. increased its stake in Aspen Aerogels by 102.6% in Q1, owning over 2.4 million shares valued at approximately $15.6 million.
• The stock of Aspen Aerogels has recently faced a decline of 2.3% and has a current market cap of $550.58 million.
• Despite a revenue drop of 33.8% year-over-year, Aspen Aerogels reported a positive earnings surprise, with an EPS of ($0.04) compared to expectations of ($0.12).

AWM Investment Company Inc. raised its position in Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) by 102.6% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,449,221 shares of the construction company's stock after acquiring an additional 1,240,535 shares during the quarter. Aspen Aerogels makes up about 2.2% of AWM Investment Company Inc.'s investment portfolio, making the stock its 12th largest holding. AWM Investment Company Inc. owned 2.98% of Aspen Aerogels worth $15,651,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Allspring Global Investments Holdings LLC lifted its stake in Aspen Aerogels by 96.2% in the first quarter. Allspring Global Investments Holdings LLC now owns 299,311 shares of the construction company's stock valued at $1,901,000 after acquiring an additional 146,794 shares during the last quarter. Janney Montgomery Scott LLC acquired a new stake in shares of Aspen Aerogels during the 1st quarter worth about $681,000. Concurrent Investment Advisors LLC acquired a new stake in shares of Aspen Aerogels during the 1st quarter worth about $109,000. BNP Paribas Financial Markets lifted its stake in shares of Aspen Aerogels by 645.4% during the 4th quarter. BNP Paribas Financial Markets now owns 135,584 shares of the construction company's stock worth $1,611,000 after buying an additional 117,395 shares during the last quarter. Finally, Exchange Traded Concepts LLC lifted its stake in shares of Aspen Aerogels by 460.4% during the 1st quarter. Exchange Traded Concepts LLC now owns 7,436 shares of the construction company's stock worth $48,000 after buying an additional 6,109 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company's stock.

Aspen Aerogels Stock Performance

Aspen Aerogels stock traded up $0.27 during midday trading on Friday, hitting $6.62. The company's stock had a trading volume of 1,844,959 shares, compared to its average volume of 1,705,162. Aspen Aerogels, Inc. has a 1-year low of $4.16 and a 1-year high of $30.24. The company has a debt-to-equity ratio of 0.34, a current ratio of 3.98 and a quick ratio of 3.31. The company has a 50-day moving average price of $7.08 and a two-hundred day moving average price of $6.52. The company has a market cap of $544.81 million, a price-to-earnings ratio of -1.74 and a beta of 2.65.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The construction company reported ($0.04) earnings per share for the quarter, topping the consensus estimate of ($0.12) by $0.08. Aspen Aerogels had a negative net margin of 78.53% and a positive return on equity of 2.92%. The business had revenue of $78.02 million during the quarter, compared to analysts' expectations of $72.53 million. During the same quarter in the previous year, the company earned $0.21 EPS. The business's revenue was down 33.8% on a year-over-year basis. Aspen Aerogels has set its FY 2025 guidance at -3.860--3.730 EPS. As a group, sell-side analysts predict that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current year.

Insider Buying and Selling

In other Aspen Aerogels news, CAO Santhosh P. Daniel sold 4,410 shares of the firm's stock in a transaction dated Tuesday, August 12th. The shares were sold at an average price of $7.31, for a total value of $32,237.10. Following the transaction, the chief accounting officer directly owned 19,879 shares of the company's stock, valued at $145,315.49. This trade represents a 18.16% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 4.30% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on ASPN shares. Canaccord Genuity Group cut their target price on shares of Aspen Aerogels from $11.00 to $10.00 and set a "buy" rating for the company in a research note on Friday, August 8th. Barclays cut shares of Aspen Aerogels from an "equal weight" rating to an "underweight" rating and raised their target price for the stock from $7.00 to $16.00 in a research note on Monday, August 11th. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Aspen Aerogels presently has an average rating of "Moderate Buy" and an average price target of $19.50.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.